-
Product Insights
Non-infectious Uveitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Non-infectious Uveitis - Drugs In Development, 2023’, provides an overview of the Non-infectious Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Non-infectious Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Uveitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Uveitis - Drugs In Development, 2023’, provides an overview of the Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Macular Edema – Drugs In Development, 2023
Global Markets Direct’s, ‘Macular Edema - Drugs In Development, 2023’, provides an overview of the Macular Edema pipeline landscape. The report provides comprehensive information on the therapeutics under development for Macular Edema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Infusion Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Infusion Systems Pipeline Market Report Overview Infusion systems are used to administer medication to a patients in critical care, emergency care, home care, and trauma centres. The infusion systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials....
-
Company Profile
Alimera Sciences Inc – Company Profile
Alimera Sciences Inc (Alimera) is a pharmaceutical company that discovers, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s product, Iluvien, is an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabetic macular edema (DME) in patients who have been previously treated with corticosteroids and did not show any clinically significant increase in intraocular pressure (IOP). Iluvien is also prescribed for the treatment of recurrent non-infectious uveitis affecting the posterior segment of the eye (NIU-PS); proliferative...
Add to Basket -
Product Insights
Alimera Sciences Inc, United States Revenue
GlobalData, the industry analysis specialist, has released its latest report: Alimera Sciences Inc, United States Revenue. The medical devices sector is typified by frequent change and innovation in available devices, in response to demand from healthcare for ever more effective therapies and increased competition. As a result, the sector has seen the emergence of start-up medtech companies who are producing the most innovative and cutting-edge solutions to problems and issues faced by the healthcare industry. Most of these companies are...
-
Product Insights
Net Present Value Model: Iluvien
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Iluvien Drug Details Fluocinolone acetonide (Iluvien,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – fluocinolone acetonide SR
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry fluocinolone acetonide SR Drug Details Fluocinolone acetonide (Iluvien, Medidur, Yutiq) is a glucocorticoid derivative....